358 related articles for article (PubMed ID: 25064148)
21. The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives.
Krettli AU
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():142-51. PubMed ID: 19753469
[TBL] [Abstract][Full Text] [Related]
22. Trypanosoma cruzi: a carbohydrate epitope defined by a monoclonal antibody as a possible marker of the acute phase of human Chagas' disease.
Ouaissi MA; Taibi A; Loyens M; Martin U; Afchain D; Maidana C; Caudioti C; Cornette J; Martelleur A; Velge P
Am J Trop Med Hyg; 1991 Aug; 45(2):214-25. PubMed ID: 1715133
[TBL] [Abstract][Full Text] [Related]
23. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
[TBL] [Abstract][Full Text] [Related]
24. Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides.
Ferreira AW; Belem ZR; Lemos EA; Reed SG; Campos-Neto A
J Clin Microbiol; 2001 Dec; 39(12):4390-5. PubMed ID: 11724850
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of FC-TRIPLEX Chagas/Leish IgG1 as confirmatory assay for non-negative results in blood bank screening of Chagas disease.
Campos FMF; Repoles LC; de Araújo FF; Peruhype-Magalhães V; Xavier MAP; Sabino EC; de Freitas Carneiro Proietti AB; Andrade MC; Teixeira-Carvalho A; Martins-Filho OA; Gontijo CMF
J Immunol Methods; 2018 Apr; 455():34-40. PubMed ID: 29395166
[TBL] [Abstract][Full Text] [Related]
26. Upgrading the flow-cytometric analysis of anti-Leishmania immunoglobulins for the diagnosis of American tegumentary leishmaniasis.
Pissinate JF; Gomes IT; Peruhype-Magalhães V; Dietze R; Martins-Filho OA; Lemos EM
J Immunol Methods; 2008 Jul; 336(2):193-202. PubMed ID: 18538785
[TBL] [Abstract][Full Text] [Related]
27. Excretory-secretory antigens of Trypanosoma cruzi are potentially useful for serodiagnosis of chronic Chagas' disease.
Nakazawa M; Rosa DS; Pereira VR; Moura MO; Furtado VC; Souza WV; Barros MN; Abath FG; Gomes YM
Clin Diagn Lab Immunol; 2001 Sep; 8(5):1024-7. PubMed ID: 11527823
[TBL] [Abstract][Full Text] [Related]
28. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
[TBL] [Abstract][Full Text] [Related]
29. The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease.
Balouz V; Melli LJ; Volcovich R; Moscatelli G; Moroni S; González N; Ballering G; Bisio M; Ciocchini AE; Buscaglia CA; Altcheh J
J Clin Microbiol; 2017 Dec; 55(12):3444-3453. PubMed ID: 28978686
[TBL] [Abstract][Full Text] [Related]
30. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic performance of tests based on Trypanosoma cruzi excreted-secreted antigens in an endemic area for Chagas' disease in Bolivia.
Zarate-Blades CR; Bladés N; Nascimento MS; da Silveira JF; Umezawa ES
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):229-32. PubMed ID: 17020793
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of an ELISA technique for detection of antigens and circulating immune complexes of Trypanosoma cruzi by a field study in an endemic zone of Argentina].
Petray P; Bonardello N; Clark R; Agranatti M; Corral R; Grinstein S
Rev Inst Med Trop Sao Paulo; 1992; 34(2):141-7. PubMed ID: 1340028
[TBL] [Abstract][Full Text] [Related]
33. Anti-fixed Leishmania chagasi promastigotes IgG antibodies detected by flow cytometry (FC-AFPA-IgG) as a tool for serodiagnosis and for post-therapeutic cure assessment in American visceral leishmaniasis.
Garcia LM; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Teixeira-Carvalho A; Rocha RD; Araújo MS; Gomes IT; Carvalho SF; Dietze R; Lemos EM; Andrade MC; Martins-Filho OA
J Immunol Methods; 2009 Oct; 350(1-2):36-45. PubMed ID: 19635482
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis.
Rocha RD; Gontijo CM; Elói-Santos SM; Teixeira-Carvalho A; Corrêa-Oliveira R; Ferrari TC; Marques MJ; Mayrink W; Martins-Filho OA
Trop Med Int Health; 2006 Feb; 11(2):156-66. PubMed ID: 16451339
[TBL] [Abstract][Full Text] [Related]
35. Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.
Gupta S; Wan X; Zago MP; Sellers VC; Silva TS; Assiah D; Dhiman M; Nuñez S; Petersen JR; Vázquez-Chagoyán JC; Estrada-Franco JG; Garg NJ
PLoS Negl Trop Dis; 2013; 7(1):e2018. PubMed ID: 23350012
[TBL] [Abstract][Full Text] [Related]
36. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
Umezawa ES; Shikanai-Yasuda MA; Stolf AM
J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
[TBL] [Abstract][Full Text] [Related]
37. Specific immunodiagnosis of Chagas disease: immunodiffusion test using a specific serum anti-Trypanosoma cruzi component 5.
Breniere FS; Carlier Y; Carrasco R; Molinedo S; Lemesre JL; Desjeux P; Afchain D
Trop Geogr Med; 1987 Jul; 39(3):281-6. PubMed ID: 3124314
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas' disease.
Reis DD; Gazzinelli RT; Gazzinelli G; Colley DG
J Immunol; 1993 Feb; 150(4):1611-8. PubMed ID: 8432996
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of anti-lived and anti-fixed Leishmania (Viannia) braziliensis promastigote IgG antibodies detected by flow cytometry for diagnosis and post-therapeutic cure assessment in localized cutaneous leishmaniasis.
Pereira VR; Reis Lde C; Souza Mde A; de Oliveira AP; de Brito ME; Lage PS; Andrade MC; Rocha RD; Martins-Filho OA
Diagn Microbiol Infect Dis; 2012 Nov; 74(3):292-8. PubMed ID: 23007034
[TBL] [Abstract][Full Text] [Related]
40. Anti-Leishmania chagasi immunoglobulin G3 detected by flow cytometry for early cure assessment in American visceral leishmaniasis.
Gomes IT; Carvalho SF; Rocha RD; Peruhype-Magalhães V; Dietze R; Martins-Filho OA; Lemos EM
J Immunol Methods; 2010 Aug; 360(1-2):76-83. PubMed ID: 20598707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
